SHENZHEN BOLANGYI TECHNOLOGY CO., LTD. – Trademark Portfolio

Entity Type: 99

SHENZHEN BOLANGYI TECHNOLOGY CO., LTD. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include GININKO. The owner is based in SHENZHEN, GUANGDONG.

811, BUILDING A, XINGHE CENTURY, NO.

3069,, CAITIAN ROAD, GANGXIA COMMUNITY, FUTIAN STREET, FUTIAN, DISTRICT,

SHENZHEN, GUANGDONG 518000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

GININKO
GININKO
Registered 2020

Trademark Classifications

SHENZHEN BOLANGYI TECHNOLOGY CO., LTD.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does SHENZHEN BOLANGYI TECHNOLOGY CO., LTD. have?

SHENZHEN BOLANGYI TECHNOLOGY CO., LTD. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does SHENZHEN BOLANGYI TECHNOLOGY CO., LTD. file in?

SHENZHEN BOLANGYI TECHNOLOGY CO., LTD. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are SHENZHEN BOLANGYI TECHNOLOGY CO., LTD.'s most well-known trademarks?

SHENZHEN BOLANGYI TECHNOLOGY CO., LTD.'s registered trademark portfolio includes well-known marks such as GININKO. These are among 1 currently registered trademark in the portfolio.

What is SHENZHEN BOLANGYI TECHNOLOGY CO., LTD.'s trademark registration success rate?

SHENZHEN BOLANGYI TECHNOLOGY CO., LTD. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.